logo
Select company
Select metric
$ -3.99MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
30
Sector
70
Industry
87
History
90
$ 3.48Close
$ 1.43 - $ 5.13 52-Week Range
Ticker Information

Ticker

TCRT

Company Name

ALAUNOS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALAUNOS THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TCRT - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ -1K$ -3.99M$ -3.99M
3/31/2025$ 0$ -4.07M$ -4.07M
12/31/2024$ 2K$ -4.68M$ -4.68M
9/30/2024$ -802K$ -11.78M$ -12.58M
6/30/2024$ 262K$ -19.13M$ -18.87M
3/31/2024$ 1.79M$ -25.71M$ -23.91M
12/31/2023$ 2.6M$ -33.22M$ -30.62M
9/30/2023$ 4.21M$ -33.65M$ -29.44M
6/30/2023$ 3.95M$ -33.18M$ -29.23M
3/31/2023$ 5.3M$ -34.67M$ -29.37M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALAUNOS THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -72.07M.
  • Over the past 5 years, ALAUNOS THERAPEUTICS INC's average EBITDA has been $ -42.21M.
  • The median EBITDA for ALAUNOS THERAPEUTICS INC during this period was $ -30.03M
  • ALAUNOS THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ -3.99M.
  • The lowest EBITDA recorded by ALAUNOS THERAPEUTICS INC in the same timeframe $ -86.97M

ALAUNOS THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
KTTA : PASITHEA THERAPEUTICS CORP $ -12.81MSLXN : SILEXION THERAPEUTICS CORP $ -11.13MGTBP : GT BIOPHARMA INC $ -9.39MCDT : CONDUIT PHARMACEUTICALS INC $ -16.52MPTIX : PROTAGENIC THERAPEUTICS INC $ -8.4MIBO : IMPACT BIOMEDICAL INC $ -36.2MOGEN : ORAGENICS INC $ -9.51MCELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -5.65MGLTO : GALECTO INC $ -16.57MTHAR : THARIMMUNE INC $ -11.99M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ALAUNOS THERAPEUTICS INC is calculated as follows: EBIT [ $ -72.95M ] + DepAmor [ $ 884K ]
(=) EBITDA [ $ -72.07M ]

TCRT - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -86.97M

Minimum

Sep 30, 2021

$ -3.99M

Maximum

Jun 30, 2025

$ -42.21M

Average

$ -30.03M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M